Human Genome Epidemiology Literature Finder
Records 1 - 10 (of 10 Records) |
Query Trace: Abnormalities and CDKN2B[original query] |
---|
Frequent genomic abnormalities in acute myeloid leukemia/myelodysplastic syndrome with normal karyotype. Haematologica 2009 Feb 94 (2): 213-23. Akagi Tadayuki, Ogawa Seishi, Dugas Martin, Kawamata Norihiko, Yamamoto Go, Nannya Yasuhito, Sanada Masashi, Miller Carl W, Yung Amanda, Schnittger Susanne, Haferlach Torsten, Haferlach Claudia, Koeffler H Phill |
Molecular screening for a personalized treatment approach in advanced adrenocortical cancer. The Journal of clinical endocrinology and metabolism 2013 Oct 98 (10): 4080-8. De Martino Maria Cristina, Al Ghuzlan Abir, Aubert Sebastien, Assié Guillaume, Scoazec Jean-Yves, Leboulleux Sophie, Do Cao Christine, Libè Rossella, Nozières Cécile, Lombès Marc, Pattou François, Borson-Chazot Francoise, Hescot Ségolène, Mazoyer Clement, Young Jacques, Borget Isabelle, Colao Annamaria, Pivonello Rosario, Soria Jean-Charles, Bertherat Jerome, Schlumberger Martin, Lacroix Ludovic, Baudin Er |
Germline and somatic mutations in cyclin-dependent kinase inhibitor genes CDKN1A, CDKN2B, and CDKN2C in sporadic parathyroid adenomas. Hormones & cancer 2013 Oct 4 (5): 301-7. Costa-Guda Jessica, Soong Chen-Pang, Parekh Vaishali I, Agarwal Sunita K, Arnold Andr |
The molecular profile of adult T-cell acute lymphoblastic leukemia: mutations in RUNX1 and DNMT3A are associated with poor prognosis in T-ALL. Genes, chromosomes & cancer 2013 Jan . Grossmann V, Haferlach C, Weissmann S, Roller A, Schindela S, Poetzinger F, Stadler K, Bellos F, Kern W, Haferlach T, Schnittger S, Kohlmann A |
Clinical and molecular characteristics of MEF2D fusion-positive B-cell precursor acute lymphoblastic leukemia in childhood, including a novel translocation resulting in MEF2D-HNRNPH1 gene fusion. Haematologica 2018 9 104 (1): 128-137. Ohki Kentaro, Kiyokawa Nobutaka, Saito Yuya, Hirabayashi Shinsuke, Nakabayashi Kazuhiko, Ichikawa Hitoshi, Momozawa Yukihide, Okamura Kohji, Yoshimi Ai, Ogata-Kawata Hiroko, Sakamoto Hiromi, Kato Motohiro, Fukushima Keitaro, Hasegawa Daisuke, Fukushima Hiroko, Imai Masako, Kajiwara Ryosuke, Koike Takashi, Komori Isao, Matsui Atsushi, Mori Makiko, Moriwaki Koichi, Noguchi Yasushi, Park Myoung-Ja, Ueda Takahiro, Yamamoto Shohei, Matsuda Koichi, Yoshida Teruhiko, Matsumoto Kenji, Hata Kenichiro, Kubo Michiaki, Matsubara Yoichi, Takahashi Hiroyuki, Fukushima Takashi, Hayashi Yasuhide, Koh Katsuyoshi, Manabe Atsushi, Ohara Akira, |
Targetable Alterations in Adult Patients With Soft-Tissue Sarcomas: Insights for Personalized Therapy. JAMA oncology 2018 May . Lucchesi Carlo, Khalifa Emmanuel, Laizet Yec'han, Soubeyran Isabelle, Mathoulin-Pelissier Simone, Chomienne Christine, Italiano Antoi |
Microarray testing as an efficient tool to redefine hyperdiploid paediatric B-cell precursor acute lymphoblastic leukaemia patients. Leukemia research 2019 May 83 106163. Lejman Monika, Zawitkowska Joanna, Styka Borys, Babicz Mariusz, Winnicka Dorota, Zaucha-Pra?mo Agnieszka, Pastorczak Agata, Taha Joanna, M?ynarski Wojciech, Kowalczyk Jerzy |
Impact of clinical features, cytogenetics, genetic mutations, and methylation dynamics of CDKN2B and DLC-1 promoters on treatment response to azacitidine. Annals of hematology 2020 1 99 (3): 527-537. Martín Iván, Navarro Blanca, Serrano Alicia, Villamón Eva, Calabuig Marisa, Solano Carlos, Chaves Felipe Javier, Yagüe Nuria, Orts Maribel, Amat Paula, Fuentes Azahara, Seda Enrique, García Francisca, Hernández-Boluda Juan Carlos, Tormo M |
Landscape of Cyclin Pathway Genomic Alterations Across 5,356 Prostate Cancers: Implications for Targeted Therapeutics. The oncologist 2021 2 26 (4): e715-e718. Jardim Denis L, Millis Sherri Z, Ross Jeffrey S, Woo Michelle Sue-Ann, Ali Siraj M, Kurzrock Razel |
Pan-Genomic Sequencing Reveals Actionable CDKN2A/2B Deletions and Kataegis in Anaplastic Thyroid Carcinoma. Cancers 2021 12 13 (24): . Stenman Adam, Yang Minjun, Paulsson Johan O, Zedenius Jan, Paulsson Kajsa, Juhlin C Christof |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: